Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -4.68% vs -2.80% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -307.14% vs -33.33% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -126.47% vs -22.73% in Sep 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -50.00% vs 100.00% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Sep 2025
Compare Quarterly Results Of New Nordic Healthbrands AB With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -4.68% vs -2.80% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -7.86% vs 10.45% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -307.14% vs -33.33% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -207.41% vs 179.41% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -126.47% vs -22.73% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -116.36% vs 266.67% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -50.00% vs 100.00% in Sep 2025
YoY Growth in quarter ended Mar 2026 is -72.73% vs 83.33% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Sep 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






